Submit Content
Get the latest delivered to your inbox
Privacy Policy

Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. 

    Illumina Named Top 100 Best Corporate Citizens and Ranked #1 in the Employee Category  Image

    POSTED 

    19 hours ago

    Illumina Named Top 100 Best Corporate Citizens and Ranked #1 in the Employee Category

    Illumina has been included for the first time on the 2022 100 Best Corporate Citizens list by 3BL Media, recognizing outstanding environmental, social, and governance (ESG) performance among the 1,000 largest U.S. public companies.
    Illumina Partners With Allelica, Inc. Image

    POSTED 

    05-12-22

    Illumina Partners With Allelica, Inc.

    Customers and our partners represent the heartbeat of Illumina. They help us advance our mission to improve human health through unlocking the power of the genome.
    Illumina and Deerfield Management Partner to Accelerate Drug Development Image

    POSTED 

    05-10-22

    Illumina and Deerfield Management Partner to Accelerate Drug Development

    Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, today announced a five-year partnership to apply a genetic-led approach to the discovery and development of novel therapies for diseases w...
    Cambridge Launchpad As Illumina Targets Five Million STEM Learners Image

    POSTED 

    05-06-22

    Cambridge Launchpad As Illumina Targets Five Million STEM Learners

    Cambridge is unveiled as the launchpad for the biggest long-term initiative ever unveiled on this side of the Atlantic to get more youngsters involved in STEM careers – thanks to US genomics giant Illumina.
    Illumina Announces Long-Term Strategic Partnership with Janssen Image

    POSTED 

    05-03-22

    Illumina Announces Long-Term Strategic Partnership with Janssen

    I’m proud to announce that today, during the World CDx Summit in London, Illumina, Inc. announced a long-term strategic collaboration with Janssen Biotech, Inc. (Janssen) to accelerate the development of precision medicines.
    Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children Image

    POSTED 

    04-28-22

    Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children

    Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced an agreement with Germany's Hannover Medical School (Medizinische Hochschule Hannover (MHH)) to implement the use of whole-genome sequencing (WGS) in critically ill children suspected of having ...
    Baby Fitz's Life-Saving Diagnosis Through Whole-Genome Sequencing Image

    POSTED 

    04-26-22

    Baby Fitz's Life-Saving Diagnosis Through Whole-Genome Sequencing

    In June 2019, Christina and Daniel Kettler were barely home from the hospital with their newborn son when they received an urgent phone call.
    Illumina Expands Access to Genomics in Latin America Through New State-of-the-Art Solution Center Image

    POSTED 

    04-14-22

    Illumina Expands Access to Genomics in Latin America Through New State-of-the-Art Solution Center

    Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of its new state-of-the-art Solution Center in São Paulo, Brazil.
    Illumina Releases Annual Corporate Social Responsibility Report Image

    POSTED 

    04-07-22

    Illumina Releases Annual Corporate Social Responsibility Report

    Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today released its annual Corporate Social Responsibility (CSR) Report, highlighting the company's 2021 environmental, social, and governance (ESG) program and commitment to human health.
    How Genomics Will Support Gorilla Conservation Image

    POSTED 

    04-06-22

    How Genomics Will Support Gorilla Conservation

    Dr. Magdalena Bermejo is calling from a 50-square-meter house deep in a rainforest in the Republic of Congo.
    Illumina logo

    Illumina

    Illumina

    Join today and get the latest delivered to your inbox